Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Value investing focuses on identifying undervalued stocks for growth. Explore strategies that can help maximize your investment returns effectively.
25,836 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Micron Technology posted a surprisingly strong AI memory quarter, triggering debate over whether the stock’s 7x forwa...
A growing share of retirees split time across states, exposing gaps in coverage from Medicare Advantage plans. Origin...
Jeff Bezos-led Blue Origin plans a $10 billion external round at a $130 billion valuation, a move that reframes priva...
Smart money decisions start with the right tools. This guide dives into the top financial planning tools for families...
Institutional hands move in the ETF space as second line capital buys into a short-maturity strategy. This article br...
Gold prices surged last year and pulled back from a record. This guide helps you decide if you should gold while it's...
A surge of quantum milestones in 2026 is fueling talk that could commercially useful quantum machines may arrive soon...
Palantir's CEO used a televised interview to question AI pricing models, highlighting data ownership and sovereignty ...
Two refining giants posted solid Q4 results, signaling a strong 2026 for the sector. The question on investors’ minds...
Investors brace for potential disruption as Trump-Iran brinkmanship over the Strait of Hormuz raises the risk of oil ...
Traders online are buzzing about turns $100k $1.28m year as a 3x semiconductor play surged over the last 12 months. T...